Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Arenberg

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Trends in Cardiovascular Medicine|January 18, 2011
The role of CXC chemokines in the regulation of angiogenesis in association with lung cancerB B Moore, D A Arenberg, R M Strieter
Current Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Chemokines as therapeutic targets in non-small cell lung cancerE S White, R M Strieter, D A Arenberg
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2001
Monocyte-fibronectin interactions, via alpha(5)beta(1) integrin, induce expression of CXC chemokine-dependent angiogenic activityE S White, D L Livant, S Markwart, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2001
Non-small cell lung cancer cells induce monocytes to increase expression of angiogenic activityE S White, S R Strom, N L Wys, et al.
Shock (Augusta, Ga.)|September 1, 1995
The role of CXC chemokines as regulators of angiogenesisR M Strieter, P J Polverini, D A Arenberg, et al.
Cancer Immunology, Immunotherapy : CII|February 28, 2001
The murine CC chemokine, 6C-kine, inhibits tumor growth and angiogenesis in a human lung cancer SCID mouse modelD A Arenberg, A Zlotnick, S R Strom, et al.
Biochemical and Biophysical Research Communications|May 5, 1995
Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesisR M Strieter, S L Kunkel, D A Arenberg, et al.
Cytokine|January 1, 1995
Regulation of monocyte-derived interleukin 1 receptor antagonist by cisplatinumD A Arenberg, S L Kunkel, M D Burdick, et al.
Cancer Immunology, Immunotherapy : CII|January 5, 2002
Improved survival in tumor-bearing SCID mice treated with interferon-gamma-inducible protein 10 (IP-10/CXCL10)D A Arenberg, E S White, M D Burdick, et al.
Proceedings of the Association of American Physicians|August 1, 1998
CXC chemokines and angiogenesis/angiostasisM P Keane, D A Arenberg, B B Moore, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Trends in Cardiovascular Medicine|January 18, 2011
The role of CXC chemokines in the regulation of angiogenesis in association with lung cancerB B Moore, D A Arenberg, R M Strieter
Current Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Chemokines as therapeutic targets in non-small cell lung cancerE S White, R M Strieter, D A Arenberg
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2001
Monocyte-fibronectin interactions, via alpha(5)beta(1) integrin, induce expression of CXC chemokine-dependent angiogenic activityE S White, D L Livant, S Markwart, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2001
Non-small cell lung cancer cells induce monocytes to increase expression of angiogenic activityE S White, S R Strom, N L Wys, et al.
Shock (Augusta, Ga.)|September 1, 1995
The role of CXC chemokines as regulators of angiogenesisR M Strieter, P J Polverini, D A Arenberg, et al.
Cancer Immunology, Immunotherapy : CII|February 28, 2001
The murine CC chemokine, 6C-kine, inhibits tumor growth and angiogenesis in a human lung cancer SCID mouse modelD A Arenberg, A Zlotnick, S R Strom, et al.
Biochemical and Biophysical Research Communications|May 5, 1995
Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesisR M Strieter, S L Kunkel, D A Arenberg, et al.
Cytokine|January 1, 1995
Regulation of monocyte-derived interleukin 1 receptor antagonist by cisplatinumD A Arenberg, S L Kunkel, M D Burdick, et al.
Cancer Immunology, Immunotherapy : CII|January 5, 2002
Improved survival in tumor-bearing SCID mice treated with interferon-gamma-inducible protein 10 (IP-10/CXCL10)D A Arenberg, E S White, M D Burdick, et al.
Proceedings of the Association of American Physicians|August 1, 1998
CXC chemokines and angiogenesis/angiostasisM P Keane, D A Arenberg, B B Moore, et al.
Pageof 4